Buminifom/Minifom for flatulence and colic in infants

Buminifom/Minifom exerts its effect locally in the gastrointestinal tract. By reducing the surface tension Buminifom/Minifom prevents foaming, affecting the gas pockets so that they dissolve.

Buminifom/Minifom drops is used to treat infantile colic

Infantile or baby colic appears from the age of two weeks and often disappears when the baby is around three to four months old. Buminifom/Minifom prevents foaming by decreasing the surface tension and affect the gas pockets to dissolve. Its effect is local and the emulsion is not absorbed by the body.

Buminifom/Minifom is sold in Swedish, Norwegian, Finnish and Icelandic pharmacies

Buminifom/Minifom (simeticone), Soft capsule, OTC, EF

ATC code

Indication area
Buminifom/Minifom is indicated to relieve colic problems by breaking down the foam and bubbles caused by flushed air. Buminifom/Minifom acts directly on the gas collections in the gastrointestinal tract and is not absorbed by the body.

Aco Hud Nordic AB (Product website)

Last SPC review

Do not use Buminifom/Minifom if hypersensitive to dimeticon or colloidal silica or any of the other ingredients. Buminifom/Minifom oral drops contain preservatives that could cause an allergic reaction.

Please carefully study the information contained in the leaflet or, as applicable, on the outer packaging. Please consult a physician before usage.

Please refer to www.fass.se for more information regarding price, more specific warnings etc.